Publication: Added value of metastatic cervical lymph node group V in nodal staging of nasopharyngeal cancer
dc.contributor.author | Jiraporn Setakornnukul | en_US |
dc.contributor.author | Kullathorn Thephamongkhol | en_US |
dc.contributor.author | Panid Chaysiri | en_US |
dc.contributor.other | Faculty of Medicine, Siriraj Hospital, Mahidol University | en_US |
dc.date.accessioned | 2020-10-05T05:38:40Z | |
dc.date.available | 2020-10-05T05:38:40Z | |
dc.date.issued | 2020-10-01 | en_US |
dc.description.abstract | © 2020 Wiley Periodicals, Inc. Background: Prognostic significance of posterior cervical lymph node metastasis in nasopharyngeal cancer is largely unknown. This study aims to determine the added prognostic significance of cervical lymph node group V to the standard American Joint Committee on Cancer (AJCC) staging system (eighth edition AJCC) of nasopharyngeal patients with cancer treated with intensity-modulated radiation therapy (IMRT) in terms of overall survival (OS), distant metastatic-free survival (DMFS), and disease-free survival (DFS). Methods and Materials: A retrospective cohort of 199 consecutively diagnosed nasopharyngeal patients with cancer treated with definitive radiotherapy (RT) or concurrent chemoradiotherapy (CCRT) in the era of IMRT in a large university hospital in endemic area of Southeast Asia. Pre-treatment imaging studies were thoroughly re-evaluated and re-staged by a board-certified radiologist using radiographic criteria for cervical lymph node metastasis. T and N classifications were reclassified according to the eighth AJCC staging system. Group V (Va and Vb) cervical node was evaluated for its added prognostic significance. Cox's proportional hazard model was used to retrieve hazard ratio (HR), 95% confidence interval and P value for N classification. Harrell's C-statistic (concordance index) was used for test of discrimination and internal validation was calculated by bootstrap method. Results: This study demonstrated greater separation of OS with HR of 6.75 (95%CI 1.94-23.51, P =.003) by using group Vb only as N3 compared to HR of 4.70 (95%CI 1.37-16.13, P =.014) by using current standard N3 disease (groups IV and Vb). Similarly, N2 with presence of Va shows worsened DFS with HR of 8.70 (95%CI 1.08-69.67, P =.042) compared to N2 without Va with HR of 5.93 (95%CI 0.76-46.00, P =.089). After incorporating cervical group V into nodal staging, the HR and 95%CI among each group was better separated than the eighth AJCC staging system but without significant improvement in C-index. Conclusion: Cervical lymph node group V is a potentially added prognostic factor to standard TNM staging. | en_US |
dc.identifier.citation | Head and Neck. Vol.42, No.10 (2020), 2801-2810 | en_US |
dc.identifier.doi | 10.1002/hed.26325 | en_US |
dc.identifier.issn | 10970347 | en_US |
dc.identifier.issn | 10433074 | en_US |
dc.identifier.other | 2-s2.0-85090263338 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/59146 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090263338&origin=inward | en_US |
dc.subject | Medicine | en_US |
dc.title | Added value of metastatic cervical lymph node group V in nodal staging of nasopharyngeal cancer | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090263338&origin=inward | en_US |